Chiara Cianciaruso

Chiara Cianciaruso

Auto-generated profile, based on publicly available information

Chiara Cianciaruso

Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2018 in Nature Cell Biology
Verified
Journal Article
Closed access
IKIoanna Keklikoglou
Ioanna Keklikoglou
CCChiara Cianciaruso
Chiara Cianciaruso
EGEsra Güç
Esra Güç
MSMario Leonardo Squadrito
Mario Leonardo Squadrito
LSLaura M. Spring
Laura M. Spring
MPMichele De Palma
Michele De Palma

31 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YJYasaman Jahani
Yasaman Jahani
EAEduardo R. Arvelo
Eduardo R. Arvelo
Filiz YesilkoyFiliz Yesilkoy
Filiz Yesilkoy
Kirill KoshelevKirill Koshelev
Kirill Koshelev
CCChiara Cianciaruso
Chiara Cianciaruso
HAHatice Altug
Hatice Altug
Biosensors are indispensable tools for public, global, and personalized healthcare as they provide tests that can be used from early disease detection and treatment monitoring to preventing pandemics. We introduce single-wavelength imaging biosensors capable of reconstructing spectral shift information induced by biomarkers dynamically using an advanced data processing technique based on an optimal linear estimator. Our method achieves superior sensitivity without wavelength scanning or spectroscopy instruments. We engineered diatomic dielectric metasurfaces supporting bound states in the continuum that allows high-quality resonances with accessible near-fields by in-plane symmetry breaking. The large-area metasurface chips are configured as microarrays and integrated with microfluidics on an imaging platform for real-time detection of breast cancer extracellular vesicles encompassing exosomes. The optofluidic system has high sensing performance with nearly 70 1/RIU figure-of-merit enabling detection of on average 0.41 nanoparticle/µm2 and real-time measurements of extracellular vesicles binding from down to 204 femtomolar solutions. Our biosensors provide the robustness of spectrometric approaches while substituting complex instrumentation with a single-wavelength light source and a complementary-metal-oxide-semiconductor camera, paving the way toward miniaturized devices for point-of-care diagnostics.

21 November 2016 in Diabetes
Verified
Journal Article
Open access
PDF file
CCChiara Cianciaruso
Chiara Cianciaruso
EPEdward A. Phelps
Edward A. Phelps
MPMiriella Pasquier
Miriella Pasquier
RHRomain Hamelin
Romain Hamelin
DDDavide Demurtas
Davide Demurtas
SBSteinunn Baekkeskov
Steinunn Baekkeskov
The target autoantigens in several organ-specific autoimmune diseases, including type 1 diabetes (T1D), are intracellular membrane proteins, whose initial encounter with the immune system is poorly understood. Here we propose a new model for how these proteins can initiate autoimmunity. We found that rat and human pancreatic islets release the intracellular β-cell autoantigens in human T1D, GAD65, IA-2, and proinsulin in exosomes, which are taken up by and activate dendritic cells. Accordingly, the anchoring of GAD65 to exosome-mimetic liposomes strongly boosted antigen presentation and T-cell activation in the context of the human T1D susceptibility haplotype HLA-DR4. Cytokine-induced endoplasmic reticulum stress enhanced exosome secretion by β-cells; induced exosomal release of the immunostimulatory chaperones calreticulin, Gp96, and ORP150; and increased exosomal stimulation of antigen-presenting cells. We propose that stress-induced exosomal release of intracellular autoantigens and immunostimulatory chaperones may play a role in the initiation of autoimmune responses in T1D.

1 June 2019 in Cell Reports
Verified
Journal Article
Open access
CCChiara Cianciaruso
Chiara Cianciaruso
TBTim Beltraminelli
Tim Beltraminelli
FDFlorent Duval
Florent Duval
SNSina Nassiri
Sina Nassiri
RHRomain Hamelin
Romain Hamelin
MPMichele De Palma
Michele De Palma
Extracellular vesicles (EVs), including exosomes, modulate multiple aspects of cancer biology. Tumor-associated macrophages (TAMs) secrete EVs, but their molecular features and functions are poorly characterized. Here, we report methodology for the enrichment, quantification, and proteomic and lipidomic analysis of EVs released from mouse TAMs (TAM-EVs). Compared to source TAMs, TAM-EVs present molecular profiles associated with a Th1/M1 polarization signature, enhanced inflammation and immune response, and a more favorable patient prognosis. Accordingly, enriched TAM-EV preparations promote T cell proliferation and activation ex vivo. TAM-EVs also contain bioactive lipids and biosynthetic enzymes, which may alter pro-inflammatory signaling in the cancer cells. Thus, whereas TAMs are largely immunosuppressive, their EVs may have the potential to stimulate, rather than limit, anti-tumor immunity.

15 November 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
DMDanusa Menegaz
Danusa Menegaz
DHD. Walker Hagan
D. Walker Hagan
JAJoana Almaça
Joana Almaça
CCChiara Cianciaruso
Chiara Cianciaruso
RRRayner Rodriguez-Diaz
Rayner Rodriguez-Diaz
EPEdward A. Phelps
Edward A. Phelps

11 August 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
AMAmaia Martinez-Usatorre
Amaia Martinez-Usatorre
EKEce Kadioglu
Ece Kadioglu
GBGael Boivin
Gael Boivin
CCChiara Cianciaruso
Chiara Cianciaruso
AGAlan Guichard
Alan Guichard
MPMichele De Palma
Michele De Palma
Lung cancer resistance to PD-1 inhibition can be overcome by targeting tumor-associated macrophages in mouse models.